Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications.
By P. Mishra, Harshita Mishra, A. Ekielski, S. Talegaonkar, Bhuvaneshwar Vaidya. Drug Discovery Today, 2017
711 citations recorded by the source corpus.
Subfields: Biomaterials, Biomedical Engineering, Materials Chemistry
View Paper: https://www.semanticscholar.org/paper/960c818a28ee316616b82942dc7e4af88836fb05
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Materials Chemistry
Citations in the corpus
- Antibacterial approaches in tissue engineering using metal ions and nanoparticles: From mechanisms to applications (2021, background): “The interaction of ZnO-NPs and Zn2+ with the cell surface is attributed to the positive charge of the zinc compound and the overall negative-charge of the bacterial membrane [53,118].”
- Use of biological nano zinc as a feed additive in quail nutrition: biosynthesis, antimicrobial activity and its effect on growth, feed utilisation, blood metabolites and intestinal microbiota (2021, background): “The differences among these results may be due to the varying bacterial strains or due to the differing methods of ZnO-NP preparation, which may affect the size and other properties of the ZnO-NPs (Mishra et al. 2017).”
- The Advancing of Zinc Oxide Nanoparticles for Biomedical Applications (2018, background): “With the development of nanomaterials, metal oxide nanoparticles show promising and far-ranging prospect for biomedical field, especially for antibacteria, anticancer drug/gene delivery, cell imaging, biosensing, and so on [1].”
- Zinc Oxide for Functional Textile Coatings: Recent Advances (2019, background): “Since these green routes are especially important for biomedical applications, the photocatalytic, antibacterial, antifungal, drug delivery, anticancer, antidiabetic, anti-inflammatory as well as bioimaging activities of ZnO NPs were taken into consideration [32,33].”
- Metal-Based Nanoparticles as Antimicrobial Agents: An Overview (2020, background): “ZnONPs have a wide distribution to organs such as the heart, spleen, liver, kidneys and lungs, accumulating specially in liver and kidneys, their main metabolic and/or excretion sites [158].”